Two recent studies looked at people at different points in their cardiovascular renal metabolic syndrome to see how common risk variables like smoking status and the quality of their sleep affected their kidney and cardiovascular disease.
A cross-sectional study that included participants from across the country found that those whose sleep quality was moderate had a 32% lower probability of having advanced stages of cardiovascular renal metabolic syndrome (CKM), while those whose sleep quality was high had a 45% lower risk. Researchers looked at five sleep behaviors—how long one sleeps, if one has trouble falling or staying asleep, whether one snores, and whether one urinates throughout the night—to gauge the quality of sleep overall. Advanced stages of CKM syndrome were substantially linked with trouble sleeping, daytime drowsiness, and nocturia (waking up at night to urinate more than once, often disrupting sleep).
Dr. Randy Gould, a cardiologist at Manhattan Cardiology in New York City who was not involved in the study, said, “Most doctors only look at things like high blood pressure, high triglycerides, glomerular filtration rate, diabetes, waist circumference, and obesity. This study, on the other hand, looks at the role of sleep quality and CKM.” Read the article.
Would you like to make an appointment with Dr. Randy Gould?
